Independent information. England-wide.Public data. Clear sources.

RESEARCH IN ENGLAND

Explore clinical trials with England locations

Search 2,970 registered studies with identifiable England locations in our dated ClinicalTrials.gov snapshot. Explore the study and local recruitment details before contacting the research team.

Clear filters

421 matching studies · ordered by study identifier.

The area filter uses exact source postcodes. Locations without a matched postcode remain in the England-wide results.

NCT06465069 · Interventional

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Metastatic Solid Tumor · Recurrent Solid Tumor · Advanced Solid Tumor · Urinary Bladder Neoplasm · Triple Negative Breast Cancer · Non-small Cell Lung Cancer · Esophageal Cancer · Pancreatic Cancer · Ovarian Cancer · Cervical Cancer · Head and Neck Squamous Cell Carcinoma · Prostate Cancer · Renal Pelvis Cancer · Bladder Cancer

Study overall: Recruiting · source record updated 4 September 2026.

2 England locations · 2 explicitly recorded as recruiting.

NCT06466135 · Interventional

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Diabetic Nephropathies · Primary Focal Segmental Glomerulosclerosis · Minimal Change Disease · Primary Immunoglobulin A Nephropathy · Primary Membranous Nephropathy

Study overall: Recruiting · source record updated 3 August 2026.

5 England locations · 2 explicitly recorded as recruiting.

NCT06535607 · Interventional

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Sub-study 1 Cervical Cancer (Volrustomig Monotherapy) · Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy) · Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy) · Sub-study 4 Esophageal Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy) · Sub-study 5 Unresectable Pleural Mesothelioma (Volrustomig Monotherapy)

Study overall: Recruiting · source record updated 6 July 2026.

2 England locations · 2 explicitly recorded as recruiting.

NCT06545331 · Interventional

Study of XB010 in Subjects With Solid Tumors

Locally Advanced or Metastatic Solid Tumors · Esophageal Squamous Cell Cancer · Head and Neck Squamous Cell Cancer · NSCLC (Non-small Cell Lung Cancer) · Hormone-receptor-positive Breast Cancer · Triple Negative Breast Cancer (TNBC)

Study overall: Recruiting · source record updated 22 June 2026.

4 England locations · 4 explicitly recorded as recruiting.

NCT06587360 · Interventional

fertiShare Evaluation

Infertility Assisted Reproductive Technology

Study overall: Recruiting · source record updated 29 July 2025.

3 England locations · 3 explicitly recorded as recruiting.

More ways to explore research

This is a selected international registry feed, not every study taking place in England. NIHR also lists participation opportunities, including studies that may not appear in this selection.

Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).

Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.

How we selected and connected these records

Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.